Surgery and Surgical Robotics
Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable rechargeable sacral neuromodulation (“SNM”) device for the treatment of urinary and bowel dysfunction, today announced the approval of the Axonics r-SNM® System by...